BlackRock Japan’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BlackRock Japan’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$47K	Buy	2,930 +649	+28%	+$11.8K	﹤0.01%	998
2016 Q3	$41K	Buy	2,281 +1,246	+120%	+$24.3K	﹤0.01%	1016
2016 Q2	$17K	Buy	+1,035	New	+$16.7K	﹤0.01%	1196
2015 Q3	–	Sell	-20,973	Closed	-$729K	–	1409
2015 Q2	$729K	Buy	+20,973	New	+$640K	﹤0.01%	763
2014 Q3	–	Sell	-1,677	Closed	-$27K	–	1352
2014 Q2	$27K	Buy	+1,677	New	+$23.9K	﹤0.01%	1126

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Japan's HZNP Position: Q4 2016 in Review

BlackRock Japan increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 28% in Q4 2016, buying an estimated $11.8K and bringing the position to 2,930 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

BlackRock Japan first reported a position in HZNP in Q2 2014 and has held it in 5 quarters since. The position peaked at $729K in Q2 2015. 234 funds tracked by Wall St. Rank hold HZNP as of Q4 2016.

BlackRock Japan held 2,930 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $47K as of Q4 2016.
BlackRock Japan bought 649 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2016, an estimated $11.8K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #998 holding.
BlackRock Japan first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and has held it in 5 quarters since.
BlackRock Japan's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $729K in Q2 2015.
234 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.